Key takeaways
Insomnia is not a common side effect of semaglutide — but some people have reported trouble sleeping while taking it.
Trouble falling or staying asleep on semaglutide might be caused by side effects such as heartburn, diarrhea, headaches, or even low blood sugar.
You can sleep better on semaglutide by sticking to a regular sleep schedule, eating lighter evening meals, and limiting caffeine and alcohol.
Talk to your healthcare provider if you are experiencing new or worsening insomnia on semaglutide.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Insomnia is not a common side effect of semaglutide — but some people have reported trouble sleeping while taking it.
Trouble falling or staying asleep on semaglutide might be caused by side effects such as heartburn, diarrhea, headaches, or even low blood sugar.
You can sleep better on semaglutide by sticking to a regular sleep schedule, eating lighter evening meals, and limiting caffeine and alcohol.
Talk to your healthcare provider if you are experiencing new or worsening insomnia on semaglutide.
You might already know that semaglutide — the active ingredient in Ozempic, Wegovy, and Rybelsus — can cause nausea and constipation. But what about other side effects? For instance, can semaglutide cause insomnia?
The short answer: Insomnia is not a known side effect of semaglutide. But some of the medication's other effects — digestive discomfort, headaches, and low blood sugar — could make it harder to sleep.
Does semaglutide cause insomnia?
Insomnia is not listed as a side effect of semaglutide medications such as Wegovy, Ozempic, or Rybelsus. But as more people use these weight loss medications, some have reported insomnia after starting treatment.
Here’s what the data suggest:
In a clinical trial, 2.4% of semaglutide users experienced insomnia — but so did 2.4% of the people given a placebo. When a side effect occurs at the same rate in both groups, it likely isn't caused by the drug.
A study of social media posts mentioning semaglutide and other GLP-1s found that some users say their sleep worsened on semaglutide, while others say it improved.
In an analysis of self-reported side effects of GLP-1s, insomnia was the most common psychiatric side effect — but still accounted for less than 1% of all reported side effects.
Research is ongoing. Yes, some people have reported semaglutide insomnia, but there’s no evidence that this is a common experience or that semaglutide directly causes insomnia.
How can semaglutide cause insomnia?
There's no evidence that semaglutide directly causes insomnia — but some of its side effects might make it harder to fall or stay asleep. For instance, semaglutide can cause:
Nausea and other gastrointestinal discomfort. Semaglutide can cause heartburn, nausea, constipation, and diarrhea. Discomfort from any of these symptoms could make it harder to relax and fall asleep.
Headaches. Some people taking semaglutide report headaches. Research shows a clear link between pain and sleep: pain can disrupt sleep, and poor sleep can worsen pain.
Changes in appetite hormones. Research shows that appetite-regulating hormones are tied to your body's internal clock. In theory, semaglutide's effects on appetite could temporarily affect sleep cues.
Low blood sugar. Semaglutide can cause hypoglycemia (low blood sugar), especially when combined with other diabetes medications. This can lead to dizziness, confusion, and a rapid heart rate — symptoms that may disrupt sleep. If you notice signs of hypoglycemia on semaglutide, let your healthcare provider know.
Sleep troubles can be tricky. Insomnia is often caused by more than one thing — physical and psychological factors both play a role. If you’re dealing with semaglutide side effects like heartburn or headaches, it’s understandable that the discomfort could affect your sleep. The good news: most of these side effects tend to improve over time.
How common is semaglutide insomnia?
Researchers still aren’t sure how common semaglutide insomnia is. There haven’t been studies on semaglutide’s direct effect on sleep.
Clinical trial data show that 2.4% of people on semaglutide experienced insomnia. But since 2.4% of people taking a placebo also experienced insomnia, it’s unlikely that the sleep issues were caused by semaglutide. While people anecdotally report sleep issues on semaglutide, further research is needed.
How to manage insomnia on semaglutide
If you're struggling to fall or stay asleep while taking semaglutide, there are ways to help. Creating a nighttime routine, eating a lighter dinner, and limiting alcohol and caffeine can all support better sleep.
Here are some strategies:
Create a nighttime routine
Sticking to a regular bedtime and routine helps tell your body it's time to wind down.
Research suggests that good sleep hygiene — a consistent bedtime, limiting light exposure, and calming your mind and body before sleep — is one of the best ways to improve your sleep in the long term. That's true whether you're on semaglutide or not.
Eat lighter in the evening
Eating heavy meals in the evening can affect your sleep even if you're not taking semaglutide. Research shows that lying down after a large meal significantly increases the risk of heartburn and nausea.
On semaglutide, a heavy dinner can compound these effects — semaglutide slows digestion, keeping you feeling full longer. Eating lighter evening meals may help reduce stomach discomfort at bedtime.
Avoid caffeine close to bedtime
Caffeine is a stimulant that increases alertness — including when you're trying to sleep. Research shows it can delay sleep onset and reduce deep sleep when consumed too late in the day. If you're already struggling to sleep on semaglutide, limiting caffeine during the day and avoiding it in the evening can help.
Limit alcohol
It might seem like alcohol would help you fall asleep — but research shows that even a drink or two at dinner can disrupt your natural sleep cycle and reduce overall sleep quality. If you think semaglutide may be affecting your sleep, try cutting back on alcohol for a week or two to see if it helps.
Know the signs of hypoglycemia
If you're taking semaglutide, it's worth knowing the early signs of hypoglycemia: lightheadedness, anxiety, palpitations, shakiness, and unusual sweating. People taking other diabetes medications or eating much less than usual while taking semaglutide should be especially cautious because they are at an increased risk of hypoglycemia. If you notice symptoms of hypoglycemia, consume a quick source of sugar like fruit juice and let your healthcare provider know.
Tell your healthcare provider
If sleep problems persist or worsen after starting semaglutide, talk to your healthcare provider. They can help identify what's causing the issue and suggest strategies to help.
Bottom line
Does semaglutide affect sleep? Indirectly, it might. Does semaglutide cause insomnia? Not exactly. Like anxiety or feeling cold, insomnia is something some people experience on semaglutide — even though it’s not typically thought of as a common side effect.
Here’s a recap on semaglutide insomnia.
Insomnia is not listed as a side effect of any semaglutide medications on the FDA labels. There’s nothing on the drug labels for Wegovy, Ozempic, or Rybelsus that suggests these medications have significant effects on sleep.
Some semaglutide side effects might impact sleep. Discomfort from gastrointestinal problems or headaches might make it harder to relax and fall asleep. In some cases, low blood sugar can cause nighttime waking.
Lifestyle changes can help you sleep better. Creating a nighttime routine, eating lighter dinners, and avoiding alcohol and caffeine can improve your sleep quality on semaglutide.
Keep your provider in the loop. You don’t have to push through semaglutide insomnia on your own. A healthcare provider can help identify what’s causing your sleep issues — and whether it's related to semaglutide or something else.
Frequently asked questions (FAQs)
How long does semaglutide insomnia last?
There haven’t been any studies specifically on semaglutide insomnia, so we can’t definitively say how long it lasts. In general, semaglutide’s side effects tend to become less intense over time as the body adjusts.
Do GLP-1s make it hard to sleep?
There’s no evidence that GLP-1s themselves make it hard to sleep — but their side effects might. For instance, nearly half of the people on Wegovy experience nausea, which can theoretically make it uncomfortable to lie down and fall asleep.
Does Wegovy cause insomnia?
No, insomnia is not a known side effect of Wegovy. There’s no evidence that semaglutide, the active ingredient in Wegovy, directly causes sleep problems. That said, some people might find it harder to fall asleep if they’re experiencing Wegovy side effects like nausea, diarrhea, or headaches.
Does Ozempic cause insomnia?
No, insomnia isn’t a known side effect of Ozempic. Some people on GLP-1 medications like Ozempic have reported trouble sleeping anecdotally, but there’s no evidence that Ozempic itself caused the problem.
Does semaglutide have a stimulant?
No, semaglutide is not a stimulant. It’s a glucagon-like peptide-1 (GLP-1) receptor agonist that regulates appetite and blood sugar — it does not have a direct effect on your energy or sleep cycle. Wegovy, Ozempic, and Rybelsus don’t contain stimulant ingredients.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
References
Arillotta, D., Floresta, G., Guirguis, A., et al. (2023). GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain Sciences, 13(11), 1503. doi: 10.3390/brainsci13111503/ Retrieved from https://www.mdpi.com/2076-3425/13/11/1503
Baranwal, N., Yu, P. K., & Siegel, N. S. (2023). Sleep physiology, pathophysiology, and sleep hygiene. Progress in Cardiovascular Diseases, 77, 59–69. doi: 10.1016/j.pcad.2023.02.005. Retrieved from https://pubmed.ncbi.nlm.nih.gov/36841492/
Boege, H. L., Bhatti, M. Z., & St-Onge, M. P. (2021). Circadian rhythms and meal timing: impact on energy balance and body weight. Current Opinion in Biotechnology, 70, 1–6. doi: 10.1016/j.copbio.2020.08.009. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7997809/
Chen, W., Cai, P., Zou, W., et al. (2024). Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database. Frontiers in Endocrinology, 15, 1330936. doi: 10.3389/fendo.2024.1330936. Retrieved from https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1330936/full?ref=ghost.glp1.guide
Drake, C., Roehrs, T., Shambroom, J., et al. (2013). Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. Journal of Clinical Sleep Medicine, 9(11), 1195–1200. doi: 10.5664/jcsm.3170. Retrieved from https://jcsm.aasm.org/doi/10.5664/jcsm.3170
Fujiwara, Y., Machida, A., Watanabe, Y., et al. (2005). Association between dinner-to-bed time and gastro-esophageal reflux disease. The American Journal of Gastroenterology, 100(12), 2633–2636. doi: 10.1111/j.1572-0241.2005.00354.x. Retrieved from https://pubmed.ncbi.nlm.nih.gov/16393212/
Inkster, B., Riha, R. L., Van Look, L., et al. (2013). Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care, 36(12), 4157–4159. doi: 10.2337/dc13-0863. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3836106/
Khurshid, K. A. (2018). Comorbid Insomnia and Psychiatric Disorders: An Update. Innovations in Clinical Neuroscience, 15(3-4), 28–32. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC5906087/
Kommu, S. & Whitfield, P. (2024). Semaglutide. StatPearls. Retrieved on Feb. 25, 2026 from https://www.ncbi.nlm.nih.gov/books/NBK603723
Mathew, P. & Thoppil, D. (2022). Hypoglycemia. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK534841/
Piacentino, D., Ogirala, A., Lew, R., et al. (2024). A Novel Method for Deriving Adverse Event Prevalence in Randomized Controlled Trials: Potential for Improved Understanding of Benefit-Risk Ratio and Application to Drug Labels. Advances in Therapy, 41(1), 152–169. doi: 10.1007/s12325-023-02695-8. Retrieved from https://link.springer.com/article/10.1007/s12325-023-02695-8
Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. doi: 10.1001/jama.2021.23619. Retrieved from https://jamanetwork.com/journals/jama/fullarticle/2787907
Seiger, A. N., Penzel, T., & Fietze, I. (2024). Chronic pain management and sleep disorders. Cell Reports. Medicine, 5(10), 101761. doi: 10.1016/j.xcrm.2024.101761. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11513819/
Smits, M. M., & Van Raalte, D. H. (2021). Safety of Semaglutide. Frontiers in Endocrinology, 12, 645563. doi: 10.3389/fendo.2021.645563. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC8294388/
Spadola, C. E., Guo, N., Johnson, D. A., et al. (2019). Evening intake of alcohol, caffeine, and nicotine: night-to-night associations with sleep duration and continuity among African Americans in the Jackson Heart Sleep Study. Sleep, 42(11), zsz136. doi: 10.1093/sleep/zsz136. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6802565/
U.S. Food & Drug Administration (FDA). (2025). Highlights of Prescribing Information: Ozempic (semaglutide) Injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
U.S. Food & Drug Administration (FDA-a). (2026). Highlights of Prescribing Information: Rybelsus (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/213051s030lbl.pdf
U.S. Food & Drug Administration (FDA-b). (2026). Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use / Wegovy (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s030lbl.pdf
Yeung, A. Y. & Tadi, P. (2023). Physiology, Obesity, Neurohormonal Appetite And Satiety Control. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK555906/














